Publikationen in Zusammenarbeit mit Forschern von Institut d'Investigacions Biomèdiques August Pi i Sunyer (19)

2024

  1. DRD4 gene polymorphism and impulse control disorder induced by dopamine agonists in Parkinson's disease

    Annals of Clinical and Translational Neurology, Vol. 11, Núm. 8, pp. 2222-2229

  2. Mitochondrial DNA deletions in the cerebrospinal fluid of patients with idiopathic REM sleep behaviour disorder

    eBioMedicine, Vol. 102

2023

  1. Midbrain and pons MRI shape analysis and its clinical and CSF correlates in degenerative parkinsonisms: a pilot study

    European Radiology, Vol. 33, Núm. 7, pp. 4540-4551

2022

  1. Cell-free mitochondrial DNA deletions in idiopathic, but not LRRK2, Parkinson's disease

    Neurobiology of Disease, Vol. 174

  2. Combined CSF α-SYN RT-QuIC, CSF NFL and midbrain-pons planimetry in degenerative parkinsonisms: From bedside to bench, and back again

    Parkinsonism and Related Disorders, Vol. 99, pp. 33-41

  3. Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body Diseases

    Movement Disorders, Vol. 37, Núm. 10, pp. 2086-2098

2020

  1. Peripheral insulin and amylin levels in Parkinson's disease

    Parkinsonism and Related Disorders, Vol. 79, pp. 91-96

  2. Transcriptomic differences in MSA clinical variants

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study

    Parkinsonism and Related Disorders, Vol. 65, pp. 3-12

  2. SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease

    Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344

2018

  1. α-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain

    Movement Disorders, Vol. 33, Núm. 4, pp. 637-641

2017

  1. Cross-sectional and longitudinal cognitive correlates of FDDNP PET and CSF amyloid-β and tau in Parkinson's disease

    Journal of Alzheimer's Disease, Vol. 55, Núm. 3, pp. 1261-1272

2014

  1. Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease

    Journal of Neuroscience Research, Vol. 92, Núm. 8, pp. 1071-1077

2013

  1. A preliminary study of the whole-genome expression profile of sporadic and monogenic early-onset Alzheimer's disease

    Neurobiology of Aging, Vol. 34, Núm. 7, pp. 1772-1778

  2. Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study

    Parkinsonism and Related Disorders, Vol. 19, Núm. 8, pp. 717-724

  3. Erratum to "Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study" [ParkinsonismRelatDisord19 (2013) 717-724]

    Parkinsonism and Related Disorders

2012

  1. Age at onset in LRRK2-associated PD is modified by SNCA variants

    Journal of Molecular Neuroscience, Vol. 48, Núm. 1, pp. 245-247

  2. Microarray expression analysis in idiopathic and LRRK2-associated Parkinson's disease

    Neurobiology of Disease, Vol. 45, Núm. 1, pp. 462-468

2002

  1. Flip and flop splice variants of AMPA receptor subunits in the spinal cord of amyotrophic lateral sclerosis

    Synapse, Vol. 45, Núm. 4, pp. 245-249